Loading...
Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
Advances in our understanding of the key mediators of chronic inflammation and tissue damage characteristic of rheumatoid arthritis (RA) have resulted in the development of novel therapies primarily targeting pro-inflammatory cytokines. Inhibitors of tumour necrosis factor (TNF) are the most widely...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Blackwell Publishing Ltd
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3042190/ https://ncbi.nlm.nih.gov/pubmed/21039421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2010.01099.x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|